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bhe JACC Editors meet on a weekly basis to select papers
or acceptance and to discuss general issues concerning the
ournal. At this week’s meeting, a spirited and animated
iscussion occurred with regard to our policy toward poten-
ial industry input into manuscripts. The influence of
ommercial entities upon papers published in JACC is, of
ourse, a matter of importance for all types of articles.
owever, vendor input presents some specific issues for
tate-of-the-Art or review-type papers. Although there was
ot universal agreement among the Editors on every point
iscussed, a general consensus did evolve. I thought this
ould be of interest to our readers, and so it is the subject
atter for this month’s Editor’s Page.
Conflict of interest, actual or potential, has become a
ajor topic for medicine in general, and cardiology is no
xception. It is clear that the medical industry now plays a
ignificant role in virtually every aspect of cardiology.
upport from commercial entities is present in medical
ducation, in basic and particularly clinical research, in
linical care in the form of direct-to-consumer advertise-
ent, and even in the organizational aspects of medicine by
irtue of the support for professional societies. The preva-
ence of such interactions led the New England Journal of
edicine to conclude that it was virtually impossible to
dentify individuals with sufficient experience and recogni-
ion to author reviews who were free of affiliations with
ndustry. It should be acknowledged that the involvement of
rug and equipment vendors with the medical establish-
ent is typically done openly, ethically, and often without
irect benefit to the vested interest of the private party.
Given the ubiquity of industry relationships, and their
enerally benign nature, the profession has settled on full
isclosure as the accepted means of dealing with the issue.
hus, it has been thought that a complete declaration of
very relationship which could possibly bias writings or
resentations would adequately deal with the potential
onflict, in that the reader/audience could take the relation-
hip into account and “judge for themselves.” This is
ertainly how JACC has approached the issue, and the
elationships declared by authors can be seen in nearly every
ssue. In fact, interaction with industry can occur at virtually
very phase of the process of publication. Authors with
elationships submit papers that are evaluated by reviewers
ith relationships, which are on occasion overseen by
ssociate Editors with relationships, and are sometimesommented upon by editorialists with relationships. cAlthough, as stated above, the standard policy is to accept
ull disclosure as sufficient action to deal with potential
onflict of interest, this does not mean that industry
elationships do not influence the peer-review process.
eviewers are usually very attuned to potential bias, and
hey often point out instances of uncritical analysis or
verstatement of the implications of research findings. Such
ssessments usually find their way into the priority scores,
hich are assigned for publication. In some cases, the
ppearance of potential conflict of interest is enough in and
f itself to recommend that a manuscript not be accepted for
ublication. Nevertheless, neither has any policy been ex-
licitly stated nor have criteria for such action been defined.
he influence of existing industry relationships upon the
eer-review process is just one of the examples of the
ubjectivity that can enter into the ultimate determination of
hich papers are accepted for publication.
At this point, I should digress to point out that affiliation
ith medical vendors can exert bias on reviewers as well as
uthors. The editors consider that one of our most impor-
ant roles is to calibrate for any influence that such relations
ay have upon referees. Although the best approach to this
roblem is to avoid soliciting reviewers for whom potential
onflicts of interest exist, these associations are often not
nown until after the critique is in. Given the realities of
cademic medicine today, even the editors are not com-
letely devoid of associations with pharmaceutical or device
ompanies. In such cases, we remove ourselves from the
eer-review process completely, usually with the assistance
f a Guest Editor. Finally, it should be acknowledged that
elationships with industry are not the only source of
onflict of interest. Professional advancement, notoriety,
nd success in competition are all strong stimuli for conflict
f interest. In fact, my impression is that the editors more
ften suspect competitive pressure as influencing the edito-
ial process, either by author or reviewer, than relations with
ndustry.
Having provided a picture of how industrial affiliations
re generally handled, one exception we have grappled with
t JACC is State-of-the-Art or review articles. These papers
nalyze original research and synthesize the results into
eneral conclusions and/or recommendations. They are
ypically authored by individuals whose expertise is evi-
enced by their own research contributions to the field and
y recognition from their peers. Therefore, these are pre-
isely the types of individuals who are sought out by industry
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March 17, 2004:1130–1 Editor’s Pages grantees, speakers, or as consultants or advisors to the
ompany. Because analysis, interpretation, and synthesis,
ften of conflicting data, are important aspects of these
apers, they are particularly susceptible to suspicions of bias,
ubconscious or otherwise. Nevertheless, as it is virtually
mpossible to find an expert who has not interacted in some
ay with a commercial entity, we have generally followed
he usual policy of disclosure in the past. However, we have
ncountered several new issues that have led to a change in
ur approach to these papers.
We have recently received a number of review-type
rticles in which industry has had a role in producing the
aper itself. In some cases a company provided financial
upport, either to offset the cost of preparing the study (e.g.,
iterature search) or even as an honorarium. In other cases a
ommercial entity directly or indirectly provided illustrative
aterial. In the cases with the greatest degree of vendor
mpact, company employees or a retained medical writer
ave helped to draft the manuscript. Such papers often
ppear as part of a supplement to a journal, which is
ponsored by a specific company and directed primarily to a
pecific drug, device, or procedure. In such cases the
otential involvement of industry is readily apparent. How-
ver, we are increasingly receiving review-type articles that
re unsolicited and arrive as stand-alone submissions. Not
urprisingly, these articles are often written by recognized
uthorities (with disclosure of industry input) and are
xtremely high quality. Nevertheless, they have been an
ncreasing source of unease and concern to the editors. In
act, we have generally declined these submissions.
On the face of it, one would think that review-type
rticles should be treated just like original research. The
uthors nearly always fully disclose their industrial relations,
he papers typically are factually accurate and well presented,
nd there is little evidence of bias. However, these articles
iffer from original research papers in that only peer-review
ournals can present original research, whereas numerous
utlets exist for review material. Given the strong involve-
ent of the medical industry with the profession today, it isot surprising that commercial entities may help provide
ducational material to physicians in “throw-away” journals,
ther medical periodicals, and medical meetings. What is
ifferent about a competitive peer-review journal like JACC
s that we provide papers with analyses and syntheses that
re as devoid as possible of input from entities with a vested
nterest in the subject. Although readers may wonder if they
ave adequately filtered any potential bias from articles with
ndustry input, they do and should feel that papers in JACC
re as free as possible from any external influence, regardless
f how soft or indirect. I must admit that this opinion is
eld only to varying degrees by individual JACC editors, but
t does reflect the consensus of the group, and certainly
epresents my own opinion.
So, where do we at JACC stand at the moment? To begin
ith, the issue of potential conflict of interest is receiving
ncreasing attention in all facets of medicine, particularly
ournals. I will address this again in more detail in a
ubsequent Editor’s Page. The editors have no desire to
ecome detectives, and they generally ascribe to the philos-
phy that full disclosure of industry relations provides
ufficient protection for readers currently. We approach
anuscripts (and reviewers) on a case-by-case basis and
ake decisions for acceptance based upon the usual multi-
aceted criteria. However, with regard to review-type pa-
ers, we have generally declined to publish those with
nancial or editorial support provided by a commercial
ntity with vested interest in the subject. We know we have
ejected some very well-written and illustrated manuscripts
n the process, and angered some authors as well. However,
e believe it is the role of JACC to provide review-type
rticles reflecting the thinking of the authors themselves, as
ree as possible from any direct or indirect influence.
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